BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 25766631)

  • 1. Design, synthesis and biological evaluation of functionalized phthalimides: a new class of antimalarials and inhibitors of falcipain-2, a major hemoglobinase of malaria parasite.
    Singh AK; Rajendran V; Pant A; Ghosh PC; Singh N; Latha N; Garg S; Pandey KC; Singh BK; Rathi B
    Bioorg Med Chem; 2015 Apr; 23(8):1817-27. PubMed ID: 25766631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydroxyethylamine Based Phthalimides as New Class of Plasmepsin Hits: Design, Synthesis and Antimalarial Evaluation.
    Singh AK; Rathore S; Tang Y; Goldfarb NE; Dunn BM; Rajendran V; Ghosh PC; Singh N; Latha N; Singh BK; Rawat M; Rathi B
    PLoS One; 2015; 10(10):e0139347. PubMed ID: 26502278
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of gallinamide A analogues as potent falcipain inhibitors and antimalarials.
    Conroy T; Guo JT; Elias N; Cergol KM; Gut J; Legac J; Khatoon L; Liu Y; McGowan S; Rosenthal PJ; Hunt NH; Payne RJ
    J Med Chem; 2014 Dec; 57(24):10557-63. PubMed ID: 25412465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docking, synthesis and antimalarial activity of novel 4-anilinoquinoline derivatives.
    Vijayaraghavan S; Mahajan S
    Bioorg Med Chem Lett; 2017 Apr; 27(8):1693-1697. PubMed ID: 28318947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing novel inhibitors against falcipain-2 of Plasmodium falciparum.
    Himangini ; Pathak DP; Sharma V; Kumar S
    Bioorg Med Chem Lett; 2018 May; 28(9):1566-1569. PubMed ID: 29602682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinoline carboxamide core moiety-based compounds inhibit P. falciparumfalcipain-2: Design, synthesis and antimalarial efficacy studies.
    Singh A; Kalamuddin M; Maqbool M; Mohmmed A; Malhotra P; Hoda N
    Bioorg Chem; 2021 Mar; 108():104514. PubMed ID: 33280833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and molecular modeling studies of derivatives of a highly potent peptidomimetic vinyl ester as falcipain-2 inhibitors.
    Ettari R; Micale N; Grazioso G; Bova F; Schirmeister T; Grasso S; Zappalà M
    ChemMedChem; 2012 Sep; 7(9):1594-600. PubMed ID: 22753258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functionalized hydroxyethylamine based peptide nanostructures as potential inhibitors of falcipain-3, an essential proteases of Plasmodium falciparum.
    Rathi B; Singh AK; Kishan R; Singh N; Latha N; Srinivasan S; Pandey KC; Tiwari HK; Singh BK
    Bioorg Med Chem; 2013 Sep; 21(17):5503-9. PubMed ID: 23810423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antimalarial effects of phenothiazine inhibitors of a Plasmodium falciparum cysteine protease.
    Domínguez JN; López S; Charris J; Iarruso L; Lobo G; Semenov A; Olson JE; Rosenthal PJ
    J Med Chem; 1997 Aug; 40(17):2726-32. PubMed ID: 9276017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel class of falcipain-2 inhibitors as potential antimalarial agents.
    Chakka SK; Kalamuddin M; Sundararaman S; Wei L; Mundra S; Mahesh R; Malhotra P; Mohmmed A; Kotra LP
    Bioorg Med Chem; 2015 May; 23(9):2221-40. PubMed ID: 25840796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Falcipain-2 inhibition by suramin and suramin analogues.
    Marques AF; Esser D; Rosenthal PJ; Kassack MU; Lima LM
    Bioorg Med Chem; 2013 Jul; 21(13):3667-73. PubMed ID: 23680445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aza vinyl sulfones: synthesis and evaluation as antiplasmodial agents.
    Glória PM; Gut J; Gonçalves LM; Rosenthal PJ; Moreira R; Santos MM
    Bioorg Med Chem; 2011 Dec; 19(24):7635-42. PubMed ID: 22071522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and evaluation of 3-methylene-substituted indolinones as antimalarials.
    Praveen Kumar S; Gut J; Guedes RC; Rosenthal PJ; Santos MM; Moreira R
    Eur J Med Chem; 2011 Mar; 46(3):927-33. PubMed ID: 21295887
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computation-based virtual screening for designing novel antimalarial drugs by targeting falcipain-III: a structure-based drug designing approach.
    Kesharwani RK; Singh DV; Misra K
    J Vector Borne Dis; 2013; 50(2):93-102. PubMed ID: 23995310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum.
    Sashidhara KV; Avula SR; Palnati GR; Singh SV; Srivastava K; Puri SK; Saxena JK
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5455-9. PubMed ID: 22850213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of new antimalarial agents: Second-generation dual inhibitors against FP-2 and PfDHFR via fragments assembely.
    Chen W; Huang Z; Wang W; Mao F; Guan L; Tang Y; Jiang H; Li J; Huang J; Jiang L; Zhu J
    Bioorg Med Chem; 2017 Dec; 25(24):6467-6478. PubMed ID: 29111368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of efficacies of cysteine protease inhibitors against five strains of Plasmodium falciparum.
    Singh A; Rosenthal PJ
    Antimicrob Agents Chemother; 2001 Mar; 45(3):949-51. PubMed ID: 11181388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fast-Acting Small Molecules Targeting Malarial Aspartyl Proteases, Plasmepsins, Inhibit Malaria Infection at Multiple Life Stages.
    Singh S; Rajendran V; He J; Singh AK; Achieng AO; Vandana ; Pant A; Nasamu AS; Pandit M; Singh J; Quadiri A; Gupta N; Poonam ; Ghosh PC; Singh BK; Narayanan L; Kempaiah P; Chandra R; Dunn BM; Pandey KC; Goldberg DE; Singh AP; Rathi B
    ACS Infect Dis; 2019 Feb; 5(2):184-198. PubMed ID: 30554511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microwave-promoted facile access to 4-aminoquinoline-phthalimides: Synthesis and anti-plasmodial evaluation.
    Rani A; Singh A; Gut J; Rosenthal PJ; Kumar V
    Eur J Med Chem; 2018 Jan; 143():150-156. PubMed ID: 29174811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Falcipain inhibitors: optimization studies of the 2-pyrimidinecarbonitrile lead series.
    Coterón JM; Catterick D; Castro J; Chaparro MJ; Díaz B; Fernández E; Ferrer S; Gamo FJ; Gordo M; Gut J; de las Heras L; Legac J; Marco M; Miguel J; Muñoz V; Porras E; de la Rosa JC; Ruiz JR; Sandoval E; Ventosa P; Rosenthal PJ; Fiandor JM
    J Med Chem; 2010 Aug; 53(16):6129-52. PubMed ID: 20672841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.